Adult Clinical Trials in Shanghai, Shanghai Municipality

26 recruitingShanghai, Shanghai Municipality, China

Showing 120 of 26 trials

Recruiting
Phase 1

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult
Grit Biotechnology31 enrolled5 locationsNCT05430373
Recruiting
Not Applicable

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours

Adult
Grit Biotechnology18 enrolled1 locationNCT06453057
Recruiting
Not Applicable

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer

Adult
Grit Biotechnology18 enrolled1 locationNCT06819280
Recruiting
Phase 2

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

Adult
Grit Biotechnology83 enrolled24 locationsNCT06241781
Recruiting
Phase 1Phase 2

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Solid Tumor, Adult
DualityBio Inc.360 enrolled36 locationsNCT06554795
Recruiting
Phase 1Phase 2

Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors

Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 1Phase 2

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+2 more
GV20 Therapeutics350 enrolled3 locationsNCT07070518
Recruiting
Phase 1

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

Refractory AMLRelapsed Adult AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine24 enrolled1 locationNCT06307054
Recruiting

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

Cushing SyndromeAdrenal InsufficiencyHealthy Adult
Shanghai 6th People's Hospital220 enrolled1 locationNCT07168122
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting

Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled58 locationsNCT06760273
Recruiting
Phase 2

Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)

Solid Tumor, Adult
Fudan University25 enrolled1 locationNCT06032845
Recruiting
Early Phase 1

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Adult Gynecological Tumors
Grit Biotechnology26 enrolled1 locationNCT06834542
Recruiting
Not Applicable

Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer

Lung CancerAdult
Grit Biotechnology40 enrolled2 locationsNCT06519669
Recruiting
Not Applicable

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)

AdultGynecological Tumors
Grit Biotechnology26 enrolled1 locationNCT06191900
Recruiting
Not Applicable

GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer

Non-small Cell Lung CancerAdult
Grit Biotechnology20 enrolled3 locationsNCT06235242
Recruiting
Phase 4

Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China364 enrolled63 locationsNCT06093191
Recruiting
Not Applicable

a Feasibility Study of iHD-SRT for BM

Brain Metastases, AdultStereotactic Radiotherapy
Ruijin Hospital35 enrolled1 locationNCT06231186
Recruiting
Not Applicable

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

Myelodysplastic SyndromeAdult Acute Myeloid LeukemiaRecurrent Adult Acute Myeloid Leukemia
Ruijin Hospital78 enrolled1 locationNCT06329999
Recruiting
Phase 1Phase 2

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

NHL, Adult
Ascentage Pharma Group Inc.51 enrolled4 locationsNCT05186012